Status:

COMPLETED

Evaluating Neuromuscular Stimulation for Restoring Hand Movements

Lead Sponsor:

Northwell Health

Conditions:

Healthy Volunteers

Spinal Cord Injury Cervical

Eligibility:

All Genders

18-65 years

Phase:

EARLY_PHASE1

Brief Summary

The specific aim of this study is to evoke functional movement in the hand of both healthy individuals and individuals diagnosed with a stable cervical spinal cord injury with non-functional movement ...

Detailed Description

In order to evaluate whether electrical stimulation applied to the muscles within the forearm can evoke functional movement in the hand, participants will receive transcutaneous electrical stimulation...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Health Volunteers:
  • Individuals between 18 and 65 years of age
  • Individuals without physical disabilities or conditions/diseases that may make them incapable of completing the physical study tasks or otherwise places them at a greater risk of harm
  • Individuals that are considered English Proficient due to the study requirements to follow verbal commands during testing sessions
  • Individuals that are able to comprehend the study goals and procedures, and are able to provide informed consent for participation
  • Individuals that are willing and able to visit the study center for study procedures, which will be up to 4 sessions a week for up to 8 weeks at up to 4 hours per session
  • Have the ability and willingness to undergo upper limb electrodiagnostic and nerve conduction studies
  • Demonstrate typical amplitude, latency, and conduction velocity in the distal median, ulnar, and radial nerves of at least one upper limb
  • Exclusion Criteria for Healthy Volunteers:
  • Individuals participating in another research study that may affect the conduct or results of this study
  • Individuals having or exhibiting any of the following:
  • Stage III-IV pressure ulcers
  • Chronically-implanted electronic medical device (e.g. baclofen pump, deep brain stimulator, epidural stimulator, cardiac pacemaker, vagus nerve stimulator, or other)
  • Prior tendon transfer to enhance hand function
  • History of autoimmune disease
  • Cancer
  • Biochemical abnormalities of the liver, kidney, or pancreas
  • Prior difficulties or allergy to general anesthesia
  • Ventilator dependence
  • History of serious mood or thought disorder
  • Significant residual clinically evident traumatic brain injury or cognitive impairment
  • Uncontrolled autonomic dysreflexia
  • Spasticity in the upper extremities that is uncontrolled by pharmacological methods
  • Individuals with a substance abuse (alcoholism or other) problem
  • Pregnant women
  • Prisoners
  • Inclusion Criteria for Participants with a Spinal Cord Injury:
  • Individuals between 18 and 65 years of age
  • Individuals with a stable cervical spinal cord injury with ISNCSCI motor scores for fingers of 0 - 2 (non-functional), and at least one year from initial spinal cord injury
  • Individuals that are considered English Proficient due to the study requirements to follow verbal commands during testing sessions
  • Individuals that are able to comprehend the study goals and procedures, and are able to provide informed consent for participation
  • Individuals that are willing and able to visit the study center for study procedures, which will be up to 4 sessions a week for up to 8 weeks at up to 4 hours per session
  • Have the ability and willingness to undergo upper limb electrodiagnostic and nerve conduction studies
  • Demonstrate typical amplitude, latency, and conduction velocity in the distal median, ulnar, and radial nerves of at least one upper limb (as expected for a person at their stage of time post spinal cord injury)
  • Exclusion Criteria for Participants with a Spinal Cord Injury:
  • Individuals participating in another research study that may affect the conduct or results of this study
  • Individuals having or exhibiting any of the following:
  • Stage III-IV pressure ulcers
  • Chronically-implanted electronic medical device (e.g. baclofen pump, deep brain stimulator, epidural stimulator, cardiac pacemaker, vagus nerve stimulator, or other)
  • Prior tendon transfer to enhance hand function
  • History of autoimmune disease
  • Cancer
  • Biochemical abnormalities of the liver, kidney, or pancreas
  • Prior difficulties or allergy to general anesthesia
  • Ventilator dependence
  • History of serious mood or thought disorder
  • Significant residual clinically evident traumatic brain injury or cognitive impairment
  • Uncontrolled autonomic dysreflexia
  • Spasticity in the upper extremities that is uncontrolled by pharmacological methods
  • Individuals with a substance abuse (alcoholism or other) problem
  • Pregnant women
  • Prisoners

Exclusion

    Key Trial Info

    Start Date :

    September 15 2017

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2023

    Estimated Enrollment :

    9 Patients enrolled

    Trial Details

    Trial ID

    NCT03385005

    Start Date

    September 15 2017

    End Date

    October 1 2023

    Last Update

    October 10 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Northwell Health's The Feinstein Institute for Medical Research

    Manhasset, New York, United States, 11030